Literature DB >> 16533487

Lymphedema.

Stanley G Rockson1.   

Abstract

Aggressively applied decongestive measures (ie, manual lymphatic drainage, low-stretch bandaging, exercise, skin care, application of compressive elastic garments) are the mainstay of lymphatic therapy. Therapeutic regimens should differentiate between the sequential goals of acute volume reduction and maintenance of limb volume. Elastic garments should not be employed until maximal volume reduction has been attained through decongestive lymphatic techniques. It is my opinion that use of intermittent pneumatic compression devices can play an important adjunctive role to decongestive lymphatic therapy but should not be substituted for these techniques. At this time, I am not inclined to use pharmacologic therapy in these patients but anxiously await the results of studies that might demonstrate efficacy for molecular approaches. Surgical intervention is reserved for a small number of well-selected patients. Liposuction for volume reduction appears to be a very promising approach for specific patients.

Entities:  

Year:  2006        PMID: 16533487     DOI: 10.1007/s11936-006-0005-y

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  45 in total

1.  Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery.

Authors:  Corradino Campisi; Francesco Boccardo
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

2.  Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.

Authors:  A Szuba; J P Cooke; S Yousuf; S G Rockson
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

Review 3.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

4.  Prognostic factors for lymphedema after primary treatment of breast carcinoma.

Authors:  A Herd-Smith; A Russo; M G Muraca; M R Del Turco; G Cardona
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

5.  Unusual complication of allergic contact dermatitis of the hands -- recurrent lymphangitis and persistent lymphoedema.

Authors:  C W Lynde; J C Mitchell
Journal:  Contact Dermatitis       Date:  1982-07       Impact factor: 6.600

6.  Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.

Authors:  Emma C Starritt; David Joseph; J Gregory McKinnon; Sing Kai Lo; Johannes H W de Wilt; John F Thompson
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

7.  Lymphoedema of the lower extremities after surgery and radiotherapy for cancer of the cervix.

Authors:  M Werngren-Elgström; D Lidman
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1994-12

8.  Lymphedema.

Authors:  G J Merli
Journal:  Clin Podiatry       Date:  1984-08

9.  Rheumatoid lymphoedema.

Authors:  V M Kyle; M De Silva; G Hurst
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

10.  Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone.

Authors:  J R Casley-Smith; R G Morgan; N B Piller
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

View more
  10 in total

1.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

2.  Maximum shortening velocity of lymphatic muscle approaches that of striated muscle.

Authors:  Rongzhen Zhang; Anne I Taucer; Anatoliy A Gashev; Mariappan Muthuchamy; David C Zawieja; Michael J Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

3.  Methods for lymphatic vessel culture and gene transfection.

Authors:  Anatoliy A Gashev; Michael J Davis; Olga Y Gasheva; Zhanna V Nepiushchikh; Wei Wang; Patrick Dougherty; Katherine A Kelly; Shijie Cai; Pierre-Yves Von Der Weid; Mariappan Muthuchamy; Cynthia J Meininger; David C Zawieja
Journal:  Microcirculation       Date:  2009-10       Impact factor: 2.628

4.  Kir6.1-dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain-of-function.

Authors:  Michael J Davis; Hae Jin Kim; Scott D Zawieja; Jorge A Castorena-Gonzalez; Peichun Gui; Min Li; Brian T Saunders; Bernd H Zinselmeyer; Gwendalyn J Randolph; Maria S Remedi; Colin G Nichols
Journal:  J Physiol       Date:  2020-05-30       Impact factor: 5.182

5.  Transcriptome analysis and functional identification of adipose-derived mesenchymal stem cells in secondary lymphedema.

Authors:  Qinqin Xiang; Fen Xu; Yunzhu Li; Xuanyu Liu; Qianlong Chen; Jiuzuo Huang; Nanze Yu; Ziyi Zeng; Meng Yuan; Qixu Zhang; Xiao Long; Zhou Zhou
Journal:  Gland Surg       Date:  2020-04

6.  Mechanisms of lymphatic regeneration after tissue transfer.

Authors:  Alan Yan; Tomer Avraham; Jamie C Zampell; Seth Z Aschen; Babak J Mehrara
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

7.  Hypoxia and extracellular matrix proteins influence angiogenesis and lymphangiogenesis in mouse embryoid bodies.

Authors:  Andrea M Foskett; Uthayashanker R Ezekiel; Jerome P Trzeciakowski; David C Zawieja; Mariappan Muthuchamy
Journal:  Front Physiol       Date:  2011-12-20       Impact factor: 4.566

8.  A new mouse model to study acquired lymphedema.

Authors:  Martin Schneider; Annelii Ny; Carmen Ruiz de Almodovar; Peter Carmeliet
Journal:  PLoS Med       Date:  2006-07-18       Impact factor: 11.069

9.  Topical bFGF Improves Secondary Lymphedema through Lymphangiogenesis in a Rat Tail Model.

Authors:  Tetsuro Onishi; Takanobu Nishizuka; Toshikazu Kurahashi; Tetsuya Arai; Katsuyuki Iwatsuki; Michiro Yamamoto; Hitoshi Hirata
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-09-08

10.  Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema.

Authors:  Sylvain Mukenge; Sawan K Jha; Marco Catena; Elena Manara; Veli-Matti Leppänen; Elisa Lenti; Daniela Negrini; Matteo Bertelli; Andrea Brendolan; Michael Jeltsch; Luca Aldrighetti
Journal:  Mol Genet Genomic Med       Date:  2020-06-26       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.